AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 1 filers reported holding AERPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $29,000 | – | 17,331 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 5,621,835 | $7,252,000 | 3.21% |
Parkman Healthcare Partners LLC | 1,001,189 | $1,292,000 | 0.30% |
ABG Innovation Capital Partners III GP Ltd | 400,000 | $516,000 | 0.25% |
Opaleye Management Inc. | 1,000,000 | $1,290,000 | 0.19% |
EcoR1 Capital, LLC | 2,072,782 | $2,674,000 | 0.12% |
Ikarian Capital, LLC | 2,651,093 | $3,420,000 | 0.12% |
Scion Asset Management | 1,000,000 | $1,290,000 | 0.10% |
Orbimed Advisors | 5,193,946 | $6,700,000 | 0.06% |
Keudell/Morrison Wealth Management | 30,694 | $40,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 302,949 | $391,000 | 0.02% |